BIA
MRVI icon

Bell Investment Advisors’s Maravai LifeSciences MRVI Stock Holding History

Bell Investment Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1K Hold
12
– – ﹤0.01% 1517
2021
Q3 		$1K Buy
+12
New +$585 ﹤0.01% 1466

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Bell Investment Advisors's MRVI Position: Q4 2021 in Review

Bell Investment Advisors held its Maravai LifeSciences (MRVI) position steady in Q4 2021 at 12 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1517.

Bell Investment Advisors first reported a position in MRVI in Q3 2021 and has held it in 2 quarters since. 229 funds tracked by Wall St. Rank hold MRVI as of Q4 2021.

  • Bell Investment Advisors held 12 shares of Maravai LifeSciences worth $1K as of Q4 2021.
  • Bell Investment Advisors left its Maravai LifeSciences share count unchanged in Q4 2021.
  • Maravai LifeSciences made up ﹤0.01% of Bell Investment Advisors's portfolio in Q4 2021, its #1517 holding.
  • Bell Investment Advisors first reported a position in Maravai LifeSciences in Q3 2021 and has held it in 2 quarters since.
  • 229 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2021.

Based on Bell Investment Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.